SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Sangamo Therapeutics, Inc. filed a voluntary Chapter 11 bankruptcy petition on June 23, 2026, in the United States Bankruptcy Court for the District of Delaware (Case No. 26-10989). The company is operating as a debtor-in-possession, with its common stock delisted from Nasdaq and trading on the OTCID Basic Market.
View raw filing on EDGAR →Synergy CHC Corp. filed a voluntary petition for relief under Chapter 11 of the Bankruptcy Code on September 4, 2026, in the U.S. Bankruptcy Court for the District of Columbia (Case No. 26-465-ELG). This is disclosed under Item 1.03 and represents a terminal event materially threatening the registrant's continued existence. The filing is accompanied by related executive departures and appointment of a chief restructuring officer, but the bankruptcy filing is the primary material event.
View raw filing on EDGAR →Charles & Colvard, Ltd. filed a voluntary Chapter 11 petition on March 2, 2026, in the U.S. Bankruptcy Court for the Eastern District of North Carolina (Case No. 26-00969-5-DMW). The Item 7.01 disclosure reports the company's monthly operating report for July 2026, which confirms the company "sold its assets during the reporting period and ceased operations" and is "working with counsel to formulate its Chapter 11 Plan." This is a terminal event—bankruptcy filing—that materially threatens the registrant's continued existence.
View raw filing on EDGAR →BioXcel Therapeutics and its subsidiaries filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code on August 27, 2026, in the U.S. Bankruptcy Court for the District of Delaware. The company will operate as debtors-in-possession and has filed for debtor-in-possession financing.
View raw filing on EDGAR →Sangamo Therapeutics filed a voluntary Chapter 11 petition on June 23, 2026, in the U.S. Bankruptcy Court for the District of Delaware (case number 26-10989), representing a terminal event materially threatening the registrant's continued existence.
View raw filing on EDGAR →Braskem has filed for extrajudicial reorganization (a Brazilian bankruptcy/reorganization proceeding) in the 2nd Bankruptcy and Judicial Reorganization Court of São Paulo. The court has granted processing of the reorganization, suspended enforcement proceedings for 120 days, and required the company to demonstrate quorum for confirmation of the reorganization plan within 90 days. This is a terminal event materially threatening the registrant's continued existence.
View raw filing on EDGAR →Braskem S.A. and five affiliated entities have filed an extrajudicial restructuring plan (Plano de Recuperação Extrajudicial) under Brazilian Bankruptcy Law (Lei nº 11.101/05) on August 24, 2026, following a preliminary injunction obtained on June 24, 2026, and concurrent Chapter 15 filings in the U.S. Bankruptcy Court for the Southern District of New York. The document explicitly references the filing of a restructuring request before the 2nd Bankruptcy Court of São Paulo and describes a significant liquidity crisis driven by prolonged petrochemical industry downcycle, oversupply, margin compression, and extraordinary obligations related to a geological event in Alagoas. This constitutes a formal bankruptcy/restructuring proceeding that materially threatens the registrant's continued existence.
View raw filing on EDGAR →Braskem's Board approved filing a petition for "extrajudicial reorganization" (reorganização extrajudicial) pursuant to Brazilian Law 11,101/05, which is Brazil's bankruptcy and insolvency law. The filing covers approximately US$10.9 billion in unsecured financial obligations. Although styled as "extrajudicial," this is a formal insolvency proceeding under Brazilian law equivalent to Chapter 11 reorganization, representing a terminal event materially threatening the registrant's continued existence.
View raw filing on EDGAR →Braskem S.A. filed a petition for extrajudicial reorganization (recuperação judicial) under Brazilian Law 11,101/05 with the 2nd Bankruptcy and Judicial Reorganization Court of São Paulo on August 24, 2026, covering unsecured financial obligations of approximately US$10.9 billion. This is a formal bankruptcy/reorganization proceeding that suspends enforceability of the Subject Claims and represents a terminal restructuring event materially threatening the registrant's continued existence in its current form.
View raw filing on EDGAR →The filing discloses that the United States District Court for the District of Wyoming appointed Robert Stevens as Receiver for Bubblr, Inc. on August 18, 2026, under Case Number 2:26-cv-00020-ABJ. This is a receivership proceeding, which is a terminal event equivalent to bankruptcy and represents the most material disclosure possible — the registrant is no longer operating under its own control and is in liquidation or restructuring proceedings.
View raw filing on EDGAR →Sangamo Therapeutics filed a voluntary Chapter 11 petition on June 23, 2026 (Case No. 26-10989), and this 8-K Item 7.01 discloses the filing of its monthly operating report for the bankruptcy case. The disclosure explicitly states the company "filed a voluntary petition for relief under Chapter 11 of Title 11 of the United States Code" and notes the company's stock has been delisted from Nasdaq and is trading on the OTC market under "SGMOQ." This is a terminal event materially threatening the registrant's continued existence.
View raw filing on EDGAR →The filing discloses that Sangamo Therapeutics filed a voluntary Chapter 11 petition on June 23, 2026 (case number 26-10989 in the U.S. Bankruptcy Court for the District of Delaware) and announces the conclusion of a court-supervised Section 363 asset auction process. While the Item 8.01 disclosure focuses on the asset sale results ($163.55 million in cash plus up to $100 million in milestones), the foundational event is the Chapter 11 bankruptcy filing itself, which is a terminal signal materially threatening the registrant's continued existence as an independent operating company.
View raw filing on EDGAR →Old QVC Group, Inc. completed a Chapter 11 bankruptcy reorganization on the Plan Effective Date, cancelling all pre-existing equity interests and substantial prepetition indebtedness including senior secured notes, revolving credit facilities, and other debt obligations. The reorganization resulted in a fundamental change of control, with new equity issued to creditors and a restructured capital base.
View raw filing on EDGAR →QVC Group, Inc. filed voluntary Chapter 11 petitions on April 16, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas. This Item 7.01 disclosure furnishes the company's monthly operating report for the period ended June 30, 2026, which is a mandatory filing requirement under the Bankruptcy Code. The filing shows total liabilities of $1.39 billion against total assets of $299 million, resulting in a deficit of $1.09 billion. This is a terminal event materially threatening the registrant's continued existence.
View raw filing on EDGAR →QVC Inc. and its affiliates filed voluntary Chapter 11 petitions on April 16, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas. This Item 7.01 disclosure furnishes the company's monthly operating report for the period ended June 30, 2026, as required by the Bankruptcy Code. The filing itself—a Chapter 11 bankruptcy—is a terminal event materially threatening the registrant's continued existence and was previously disclosed in an April 16, 2026 8-K. This current disclosure updates investors on the company's financial condition during bankruptcy proceedings, showing cumulative losses of $61.7 million and negative equity of $5.4 billion as of June 30, 2026.
View raw filing on EDGAR →Hughes Satellite Systems Corporation (HSSC), a subsidiary of EchoStar Corporation, and eleven of its wholly-owned subsidiaries filed voluntary petitions for reorganization under Chapter 11 of the United States Bankruptcy Code in the U.S. Bankruptcy Court for the District of Texas on August 2–3, 2026, seeking to operate as debtors-in-possession and continue ordinary course operations.
View raw filing on EDGAR →On July 31, 2026, UMB Bank (acting through OIC Structured Equity Fund I GPFA Range, LLC) filed a petition with the High Court of Ireland seeking winding up and liquidation of Carbon Revolution Public Limited Company under section 569(1)(d) of the Companies Act 2014 on grounds of insolvency. The High Court subsequently appointed joint liquidators on a provisional basis, with a hearing scheduled for October 19, 2026. This constitutes a bankruptcy/insolvency filing under Irish law—a terminal event materially threatening the registrant's continued existence.
View raw filing on EDGAR →Although the bankruptcy petition was filed on March 2, 2026 (previously disclosed), this Item 7.01 disclosure is a Regulation FD filing of the company's monthly operating report for the period ended June 30, 2026, filed with the Bankruptcy Court on July 27, 2026. The disclosure explicitly references the ongoing Chapter 11 case (In re Charles & Colvard, Ltd., Case No. 26-00969-5-DMW) and includes detailed bankruptcy court filings and monthly operating reports showing the company operating as a debtor-in-possession. The company cautions that "trading in the Company's common stock during the pendency of the Chapter 11 Case is highly speculative" and that shareholders "may experience a significant or complete loss." This is a terminal event materially threatening the registrant's continued existence.
View raw filing on EDGAR →QVC Group, Inc. filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code on April 16, 2026, and the Bankruptcy Court confirmed the Second Amended Joint Prepackaged Plan of Reorganization on July 20, 2026. The filing discloses the plan's material terms, including cancellation of all existing equity interests for no consideration and restructuring of debt claims. This is a terminal event materially threatening the registrant's continued existence, requiring classification as bankruptcy_filing under Item 1.03.
View raw filing on EDGAR →QVC Inc. and its affiliates filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code on April 16, 2026, with the Bankruptcy Court confirming the Second Amended Joint Prepackaged Plan of Reorganization on July 20, 2026. The filing discloses the plan's material terms, including cancellation of all existing equity interests for no consideration and restructuring of debt claims. This is a terminal event materially threatening the registrant's continued existence.
View raw filing on EDGAR →Vicarious Surgical Inc. entered into a general assignment for the benefit of creditors (ABC) on July 21, 2026, transferring substantially all assets to a liquidation entity. This non-judicial insolvency proceeding is functionally equivalent to bankruptcy and represents a terminal event materially threatening the registrant's continued existence.
View raw filing on EDGAR →GoHealth, Inc. filed a voluntary Chapter 11 bankruptcy petition on June 7, 2026, and emerged from bankruptcy on July 21, 2026, following confirmation of its prepackaged plan by the U.S. Bankruptcy Court for the District of Delaware on July 20, 2026. The plan converted the company into a limited liability company (New GoHealth, LLC), cancelled all existing equity interests, and issued 100% of new common interests to holders of Allowed First Lien Claims on a pro rata basis, fundamentally restructuring the company's capital structure and security holder rights.
View raw filing on EDGAR →Sangamo Therapeutics filed a voluntary petition for Chapter 11 bankruptcy relief on June 23, 2026 (Case No. 26-10989) in the U.S. Bankruptcy Court for the District of Delaware. The company is operating as a debtor-in-possession and has obtained court approval for bidding procedures to sell substantially all assets.
View raw filing on EDGAR →QVC Inc. filed voluntary Chapter 11 bankruptcy petitions on April 16, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas. This Item 7.01 disclosure furnishes the company's monthly operating report for May 2026 and a press release announcing confirmation of the company's prepackaged restructuring plan by the Bankruptcy Court on July 15, 2026. The filing is a terminal event materially threatening the registrant's continued existence as an independent operating entity.
View raw filing on EDGAR →QVC Group, Inc. filed voluntary Chapter 11 petitions on April 16, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas. This Item 7.01 disclosure furnishes the company's monthly operating report for May 2026 and a press release announcing confirmation of the company's prepackaged financial restructuring plan. The filing explicitly references the Chapter 11 Cases and the Bankruptcy Court's confirmation ruling, making this a terminal bankruptcy event that is material to any reasonable investor assessing the registrant's continued existence.
View raw filing on EDGAR →On June 17, 2026, the District Court of Clark County, Nevada appointed Peter D. Downey as Receiver for Fuse Science, Inc. pursuant to NRS 78.650 and NRS 32.010, finding the company insolvent with zero assets and zero cash, unable to meet its obligations, and at substantial risk of asset dissipation. The court-ordered receivership constitutes a terminal event equivalent to bankruptcy, placing the company under judicial supervision for liquidation and winding down of its affairs.
View raw filing on EDGAR →Inotiv's Chapter 11 plan of reorganization was confirmed by the U.S. Bankruptcy Court for the Southern District of Texas on July 14, 2026, following the company's voluntary petition filing on June 3, 2026. All outstanding common shares will be canceled and existing equity holders will receive no distribution, with the company expected to emerge as a private entity with a restructured capital structure.
View raw filing on EDGAR →Lipella Pharmaceuticals filed a voluntary Chapter 11 petition on March 30, 2026, and subsequently entered into an Asset Purchase Agreement with XRAIY on May 14, 2026, approved by the Bankruptcy Court on June 4, 2026. The filing discloses the bankruptcy case number (26-20879-CMB) and the sale of substantially all company assets under Section 363 of the Bankruptcy Code, which is a terminal event materially threatening the registrant's continued existence as an independent entity.
View raw filing on EDGAR →Sangamo Therapeutics filed a voluntary petition for relief under Chapter 11 of the Bankruptcy Code, with the company's common stock beginning trading on the OTC Basic Market on June 24, 2026 as a result of the bankruptcy filing.
View raw filing on EDGAR →MTI has filed a Plan of Reorganization in Chapter 11 bankruptcy cases involving its subsidiaries BMI OldCo Inc. and affiliated debtors. The filing discloses a $290 million charge to reserves in Q2 2026 and a proposed $450 million funding commitment for a talc personal injury trust. This is a terminal event materially threatening the registrant's financial position and operations, centered on bankruptcy proceedings and the associated restructuring obligations.
View raw filing on EDGAR →The Board of Directors unanimously approved resolution PD.CA/BAK-20/2026 authorizing the institution of a mediation proceeding with financial creditors and the commencement of judicial proceedings for Emergency Precautionary Relief under Article 20-B of Brazil's Law No. 11.101/2005 (the insolvency law), as well as potential Chapter 15 ancillary proceedings in the United States. This constitutes a material bankruptcy or insolvency filing—the company is seeking protective measures and formal restructuring proceedings, which is a terminal event materially threatening the registrant's continued existence.
View raw filing on EDGAR →Office Properties Income Trust emerged from Chapter 11 bankruptcy reorganization under the Fourth Amended Joint Chapter 11 Plan of Reorganization filed April 21, 2026 with the U.S. Bankruptcy Court for the Southern District of Texas. The emergence resulted in cancellation of all pre-bankruptcy common shares and senior notes, termination of the DIP Credit Agreement, and a complete restructuring of the company's capital structure and ownership.
View raw filing on EDGAR →Sangamo Therapeutics filed a voluntary petition for relief under Chapter 11 of the Bankruptcy Code on June 23, 2026 (Case No. 26-10989) in the U.S. Bankruptcy Court for the District of Delaware. The company will operate as a debtor-in-possession and has filed motions for first-day relief and debtor-in-possession financing.
View raw filing on EDGAR →The filing discloses that Fat Brands Inc. and its subsidiaries, including Twin Hospitality Group Inc., commenced voluntary Chapter 11 bankruptcy cases on January 26, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas. The 8-K documents the bankruptcy proceedings, asset sales conducted pursuant to bankruptcy court orders, and the completion of multiple asset dispositions. While the filing also contains M&A activity (asset sales), the foundational event is the Chapter 11 filing itself, which is the terminal signal requiring disclosure.
View raw filing on EDGAR →The filing discloses that QVC Group, Inc. and certain affiliates filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Texas on April 16, 2026. While this 8-K is technically filed under Item 7.01 (Regulation FD Disclosure) to furnish monthly operating reports required by the Bankruptcy Code, the core material event is the Chapter 11 bankruptcy filing itself, which was previously disclosed on April 16, 2026. This is a terminal signal event of the highest materiality.
View raw filing on EDGAR →QVC Inc. and its affiliates filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of Texas on April 16, 2026. Although this Item 7.01 disclosure focuses on the filing of monthly operating reports required by the Bankruptcy Code, it explicitly references and incorporates the prior 8-K filing disclosing the Chapter 11 Cases themselves. The bankruptcy filing is the material event that triggered this disclosure and is terminal in nature, representing the most significant financial distress signal.
View raw filing on EDGAR →Sleep Number Corporation has filed for Chapter 11 bankruptcy protection and entered into a debtor-in-possession (DIP) financing agreement providing $260 million in committed financing to support operations during the reorganization process.
View raw filing on EDGAR →Sleep Number Corporation and its subsidiaries filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code on June 12, 2026, in the U.S. Bankruptcy Court for the Southern District of New York. The filing triggered automatic acceleration of approximately $672.5 million in debt and includes debtor-in-possession financing and a stalking horse asset sale agreement.
View raw filing on EDGAR →GoHealth, Inc. and its subsidiaries filed voluntary petitions under Chapter 11 of the Bankruptcy Code on June 7, 2026, in the U.S. Bankruptcy Court for the District of Delaware, with the company operating as debtors-in-possession under a prepackaged chapter 11 plan of reorganization.
View raw filing on EDGAR →Inotiv and its subsidiaries filed voluntary petitions under Chapter 11 of the Bankruptcy Code on June 3, 2026. The company entered into a debtor-in-possession financing facility on June 5, 2026 to fund operations during the reorganization proceedings.
View raw filing on EDGAR →Silver Star Properties REIT, Inc. filed a voluntary petition for relief under Chapter 11 of the Bankruptcy Code on May 28, 2026, in the United States Bankruptcy Court for the Northern District of Texas (Case No. 26-42316-mxm11), with a subsidiary (Silver Star Virginia Parkway, LLC) filing a separate Chapter 11 petition on the same date.
View raw filing on EDGAR →On October 30, 2025, the Company and its debtor affiliates commenced voluntary Chapter 11 bankruptcy cases in the United States Bankruptcy Court for the Southern District of Texas (Case No. 25-90530). The Company is operating as a debtor-in-possession and has filed Monthly Operating Reports with the Bankruptcy Court.
View raw filing on EDGAR →The filing discloses that FAT Brands Inc. and its subsidiaries, including Twin Hospitality Group Inc., commenced voluntary Chapter 11 bankruptcy cases on January 26, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas. The 8-K reports on the approval of a Global Settlement and Final DIP Order on May 19, 2026, which resolves objections and establishes a plan for asset sales and liquidation. This is a terminal bankruptcy event with material consequences for creditors and equity holders.
View raw filing on EDGAR →Inotiv, Inc. filed voluntary Chapter 11 bankruptcy petitions on June 3, 2026, to implement a comprehensive restructuring plan under a Restructuring Support Agreement with consenting lenders and noteholders. The company is operating as a debtor-in-possession and has sought first-day relief including DIP financing authority, with the plan contemplating debt-for-equity conversion, cancellation of existing equity, and issuance of new equity to creditors.
View raw filing on EDGAR →Trinseo PLC filed for Chapter 11 bankruptcy protection and entered into debtor-in-possession (DIP) financing arrangements, including a $270M OpCo facility and $157.5M Super-Holdco facility, to fund operations and administrative costs during the reorganization process.
View raw filing on EDGAR →Trinseo PLC filed voluntary petitions under Chapter 11 of the Bankruptcy Code on May 26, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas, and will operate as a debtor-in-possession. The filing includes a press release, Disclosure Statement for creditors voting on a reorganization plan, and Combined Notice of the Chapter 11 Cases, with cautionary language that existing equity holders are expected to have their equity interests cancelled and will receive no recovery.
View raw filing on EDGAR →